Concepedia

Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial

Mauro P. Ferrari, Flavio Mantelli, Marta Sacchetti, Maria Irene Antonangeli, Franca Cattani, Gaetano D’Anniballe, Francesco Sinigaglia, Pier Adelchi Ruffini, Alessandro Lambìase

BioDrugs · 2013 · 73 citations · 18 references

DOIFull text

Open access

Abstract

rhNGF eye drops were well tolerated, with no detectable clinical evidence of systemic AEs. These results pave the way for the development of clinical trials on rhNGF in ophthalmology.

References

18

p75 and Trk: A two-receptor system

Moses V. Chao, Barbara L. Hempstead · Trends in Neurosciences · 1995 · 859 citations

, , +6

Human β-nerve growth factor gene sequence highly homologous to that of mouse

Axel Ullrich, Alane Gray, Cara Berman et al. · Nature · 1983 · 483 citations

, , +6

Competitive Signaling Between TrkA and p75 Nerve Growth Factor Receptors Determines Cell Survival

Sung Ok Yoon, Patrizia Casaccia‐Bonnefil, Bruce Carter et al. · Journal of Neuroscience · 1998 · 474 citations · Full text

Topical Treatment with Nerve Growth Factor for Corneal Neurotrophic Ulcers

Alessandro Lambìase, Paolo Rama, Stefano Bonini et al. · New England Journal of Medicine · 1998 · 414 citations · Full text

Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy

Stuart C. Apfel, Sherwin Schwartz, Bruce T. Adornato et al. · JAMA · 2000 · 354 citations